ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

OPTI Optibiotix Health Plc

18.25
0.00 (0.00%)
31 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Optibiotix Health Plc LSE:OPTI London Ordinary Share GB00BP0RTP38 ORD 2P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 18.25 17.50 19.00 18.25 18.25 18.25 44,934 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Noncomml Resh Organizations 457k 2.59M 0.0284 6.43 16.64M
Optibiotix Health Plc is listed in the Noncomml Resh Organizations sector of the London Stock Exchange with ticker OPTI. The last closing price for Optibiotix Health was 18.25p. Over the last year, Optibiotix Health shares have traded in a share price range of 5.75p to 43.50p.

Optibiotix Health currently has 91,190,661 shares in issue. The market capitalisation of Optibiotix Health is £16.64 million. Optibiotix Health has a price to earnings ratio (PE ratio) of 6.43.

Optibiotix Health Share Discussion Threads

Showing 23701 to 23724 of 147675 messages
Chat Pages: Latest  951  950  949  948  947  946  945  944  943  942  941  940  Older
DateSubjectAuthorDiscuss
25/4/2017
07:41
OptiBiotix will continue to use THWLC to incubate new technological solutions and establish early consumer interest and product viability. It believes this is an effective way to attract interest from industry partners who want to use Slimbiome(R) as a food ingredient in other products in other product applications and international markets.

Will this be the route to launch LP-LDL in May or will it be through other partners?

fozdad
25/4/2017
07:34
Results very much as expected. Revenue covers a very short period following a soft launch. Not concerned about this. So much going on. Well financed and a leader in its field. Would like to know more about shareholder dividend from Skin demerger.
rafboy
25/4/2017
07:34
Share price projections?
luisfrg
25/4/2017
07:34
SoH's comment on GoFifure products at UK Investor:

"They're being sold quicker than we can make them at the moment, there is huge demand".

colinzeal
25/4/2017
07:29
The company will look very different in 12 months time:In the last 12 months commercial deals have focused on joint development, cost sharing, or option agreements with partners contributing funding in return for certain future rights. The next 12 months will see the Company transition from a technology company to a product company building revenues streams from a diverse range of products. Interesting to hear that Christina will be focusing on slimbiome and Per on LP-LDL. I guess it make sense to become an expert in one product area.All very positive IMO.
parob
25/4/2017
07:28
Market Cap £57million - Revenues £288k!
flavio_monteiro
25/4/2017
07:26
adorling,go figure launched in Aug 2016 the £288k is to the end of Nov 2016,personally quite happy with that.
scotty1
25/4/2017
07:24
more jam tomorrow
tsmith2
25/4/2017
07:23
ffs ... these are good. £3.1m cash. Loads going on. Rev just over 300k but remember go figure only launched mid 2016 and these results are to nov 2016. give them a chance !!!
meganxmas
25/4/2017
07:22
product doesn't hit market until May does it? Market will be looking forward IMO....also, in due course I am sure it will look to off load more of subsidiary to release cash...let's see DYOR...interesting times....road show will be key to drumming up demand for shares IMO
qs99
25/4/2017
07:19
Somewhat underwhelmed by £288k revenue...
adorling
25/4/2017
07:17
All sounds very positive.

"The Groups cash position remains strong at GBP3,115,366 (2015: GBP2,040,888) which is sufficient to fund its existing research and development programmes, extend technology platforms into other product and application areas, and support the sales and marketing of our pipeline of products."

someuwin
25/4/2017
07:11
Sorry spotted now near the end just under £300k.
deeppockets
25/4/2017
07:09
No mention of revenues?
deeppockets
25/4/2017
07:09
Results out...
luisfrg
24/4/2017
23:16
Thanks jh, I'll take a look;¬)

M

marnewton
24/4/2017
19:59
Marnewton i think you maybe be interested in TRIN, very strong fundamentals and a sweet looking chart.
john henry
24/4/2017
16:38
O/T

Cheers griffin, SDX certainly has a stronger chart, I'll keep an eye on it;¬)

M

marnewton
24/4/2017
16:12
Kipper - Quite a few of us have report the same over the past couple of years. All my buys have shown as sells. Its part of the course with OPTI. MM's are sneaky gets.
elrico
24/4/2017
15:57
actually, its just popped up - and its showing BOTH as SELL. So, that's 56,000 SELLs that didn't happen.
kipper1960
24/4/2017
15:54
I have just Bed & ISA'ed some of my OPTI shares; strangely it is only showing one of the transactions (28,050 shares) and its showing up as a sell. If that is happening across the board it could be giving a very distorted view of the BUY/SELL ratio.
kipper1960
24/4/2017
15:53
Scotty - Agreed, I'm expecting some encouraging comments, guidance on what we can expect in H2 and possibly early NY. The numbers will be meaningless, but it will serve to excite at least one individual, whom I am sure will put his unique spin on them :))
elrico
24/4/2017
15:23
diamond give us a clue now what said news is or imo your post as no credibility what so ever.
scotty1
24/4/2017
15:07
Elrico no not expecting much regarding revenues yet,but i'm expecting the outlook statement to be pretty damn good.
scotty1
Chat Pages: Latest  951  950  949  948  947  946  945  944  943  942  941  940  Older

Your Recent History

Delayed Upgrade Clock